AddLife AB - Class B

OSTO:ALIF B (Sweden)   Class B
kr 113.00 (-0.44%) Jun 4
173.85
P/B:
2.67
Market Cap:
kr 13.77B ($ 1.32B)
Enterprise V:
kr 19.03B ($ 1.82B)
Volume:
62.46K
Avg Vol (2M):
106.61K
Also Trade In:
Volume:
62.46K
Avg Vol (2M):
106.61K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for AddLife AB ( ) from 2016 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. AddLife AB stock (OSTO:ALIF B) PE ratio as of Jun 05 2024 is 173.85. More Details

AddLife AB (OSTO:ALIF B) PE Ratio (TTM) Chart

To

AddLife AB (OSTO:ALIF B) PE Ratio (TTM) Historical Data

Total 1281
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
AddLife AB PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-05 173.8 2024-03-28 172.3
2024-06-04 173.8 2024-03-27 70.5
2024-06-03 174.6 2024-03-26 71.4
2024-05-31 176.0 2024-03-25 71.1
2024-05-30 174.9 2024-03-22 70.1
2024-05-29 171.5 2024-03-21 71.3
2024-05-28 173.1 2024-03-20 68.8
2024-05-27 180.0 2024-03-19 67.3
2024-05-24 172.3 2024-03-18 66.1
2024-05-23 174.2 2024-03-15 67.3
2024-05-22 174.2 2024-03-14 69.0
2024-05-21 169.2 2024-03-13 69.2
2024-05-20 175.2 2024-03-12 69.7
2024-05-17 177.2 2024-03-11 68.6
2024-05-16 175.5 2024-03-08 67.5
2024-05-15 174.9 2024-03-07 65.5
2024-05-14 170.8 2024-03-06 63.3
2024-05-13 167.2 2024-03-05 61.2
2024-05-10 166.5 2024-03-04 64.5
2024-05-08 165.2 2024-03-01 66.1
2024-05-07 162.3 2024-02-29 64.6
2024-05-06 158.3 2024-02-28 64.5
2024-05-03 156.9 2024-02-27 65.5
2024-05-02 153.8 2024-02-26 64.5
2024-04-30 157.8 2024-02-23 65.4
2024-04-29 157.5 2024-02-22 65.8
2024-04-26 151.8 2024-02-21 65.2
2024-04-25 148.8 2024-02-20 65.0
2024-04-24 161.8 2024-02-19 66.4
2024-04-23 152.4 2024-02-16 66.1
2024-04-22 149.0 2024-02-15 66.8
2024-04-19 151.1 2024-02-14 67.3
2024-04-18 150.5 2024-02-13 66.2
2024-04-17 150.6 2024-02-12 67.3
2024-04-16 152.8 2024-02-09 72.5
2024-04-15 156.8 2024-02-08 75.4
2024-04-12 158.5 2024-02-07 70.9
2024-04-11 164.6 2024-02-06 70.5
2024-04-10 161.5 2024-02-05 70.9
2024-04-09 164.3 2024-02-02 71.9
2024-04-08 165.5 2024-02-01 72.1
2024-04-05 164.6 2024-01-31 72.7
2024-04-04 166.9 2024-01-30 75.2
2024-04-03 167.1 2024-01-29 74.3
2024-04-02 168.8 2024-01-26 72.8

AddLife AB (OSTO:ALIF B) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.